Latest news
Sophia Genetics expands AstraZeneca partnership with two cDX programs - AllSciAllSci · Thu, 06 Aug 2026 13:57:38 GMTCSPC Pharmaceutical & AstraZeneca Form Joint Venture for Biologics Manufacturing in China - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 14:02:36 GMTSophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 17:52:13 GMTM&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Enters Merger Agreement with Lantheus - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 14:07:34 GMTSOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - PR NewswirePR Newswire · Tue, 04 Aug 2026 10:15:00 GMTSOPHiA GENETICS Plans Tests for Solid Tumors, Blood Cancer - Stock TitanStock Titan · Tue, 04 Aug 2026 10:15:00 GMTPathos AI Enters Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERα PROTAC for ER+ Breast Cancer into the Clinic - Business WireBusiness Wire · Tue, 04 Aug 2026 00:00:00 GMTPathos AI and AstraZeneca Enter Collaboration and Co-Exclusive Licensing Agreement to Advance Novel ERa PROTAC for ER+ Breast Cancer into the Clinic - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 22:00:00 GMT